This inventor holds 1 USPTO granted patent. Top assignee: Cytolynx Therapeutics Hong Kong Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ning Li - Innovator in Monoclonal Antibody Research
Introduction
Ning Li is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Ning Li holds a patent for a "Humanized Monoclonal Antibody Targeting BCMA and Having Human Monkey Cross-Reactivity." This patent represents a significant advancement in the development of targeted therapies, showcasing her expertise in antibody engineering.
Career Highlights
Ning Li is currently associated with Cytolynx Therapeutics Hong Kong Limited, where she continues to push the boundaries of scientific research. Her work at Cytolynx Therapeutics focuses on developing novel therapeutic solutions that address unmet medical needs.
Collaborations
Ning Li collaborates with esteemed colleagues, including Guoqing Cao and Guojun Lang. These partnerships enhance her research capabilities and contribute to the advancement of innovative therapies.
Conclusion
Ning Li's contributions to monoclonal antibody research exemplify her dedication to innovation in biotechnology. Her patent and ongoing work at Cytolynx Therapeutics highlight her role as a key player in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile